Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:05:24.947Z.
Calculation as of: 2026-10-06T18:05:24.947Z.
Quote observation: 2026-10-06T17:59:30.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
EARNINGS YIELD
N/A
Market Cap
$267.85M
Earnings Yield
N/A
TTM Avg
0.57%
3Y Avg
0.57%
5Y Avg
0.57%
Market Cap
$263.79M
Earnings Yield
N/A
TTM Avg
6.60%
3Y Avg
6.60%
5Y Avg
6.49%
Market Cap
$262.79M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.97M
Earnings Yield
N/A
TTM Avg
7.35%
3Y Avg
8.08%
5Y Avg
6.30%
Market Cap
$269.68M
Earnings Yield
N/A
TTM Avg
17.92%
3Y Avg
17.92%
5Y Avg
17.92%
Market Cap
$261.15M
Earnings Yield
N/A
TTM Avg
24.17%
3Y Avg
24.17%
5Y Avg
24.17%
Market Cap
$269.87M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$270.82M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scribe Therapeutics Inc. (SCTX) | $267.33M | N/A | N/A | N/A | N/A |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $267.85M | N/A | 0.57% | 0.57% | 0.57% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $263.79M | N/A | 6.60% | 6.60% | 6.49% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $262.79M | N/A | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $261.97M | N/A | 7.35% | 8.08% | 6.30% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $269.68M | N/A | 17.92% | 17.92% | 17.92% |
| Palisade Bio, Inc. (PALI)vs › | $261.15M | N/A | 24.17% | 24.17% | 24.17% |
| Treace Medical Concepts, Inc. (TMCI)vs › | $269.87M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.82M | N/A | N/A | N/A | N/A |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $270.31M | N/A | 4.11% | 3.31% | 6.16% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
